Skip to content 
Search

Latest Stories

Europe acts to secure supplies of essential medicines

European Commission published its first list of critical medicines, as part of a wider overhaul of laws governing the €136 billion (£117bn) pharmaceuticals industry

Europe acts to secure supplies of essential medicines

THE European Commission published its first list of critical medicines, as part of a wider overhaul of laws governing the €136 billion (£117bn) pharmaceuticals industry aimed at avoiding shortages of drugs.

It is the biggest change to existing medical laws in two decades. The law is aimed at ensuring all Europeans have access to both innovative new treatments and generic drugs and ending huge divergences in access and prices between countries.


“The inclusion on this list is not an indication that a medicine is likely to experience a shortage in the near future. Rather, it signifies the critical importance of averting shortages for these specific medicines,” the commission said.

The list, published by the European Medicines Agency, includes a wide range of essential, generic medicines, from basic antibiotics such as amoxicillin, painkillers like paracetamol and morphine and insulin used to treat diabetes.

The list also includes some vaccines for measles, hepatitis B and tetanus.

“During 2024 the review will continue and extend to other authorised medicines in the EU not yet included in the first version,” the commission added.

Many member states are keen to see a Critical Medicines Act, similar to Critical Minerals Act, to create more resilient supply chains and avoid over-reliance on countries such as China and India that produce most generic drugs and basic equipment.

In October, the commission launched some short-term measures in order to prevent medicine shortages this winter and the next as a stop-gap while the new pharmaceutical rules are hashed out.

The new proposed law includes measures that would cut the length of basic market exclusivity that drugmakers get before generics can enter the market to eight from 10 years.

European pharmaceutical executives have repeatedly warned that this measure would backfire and accelerate a trend of waning medical innovation in the EU.

Lars Fruergaard Jorgensen, CEO of Novo Nordisk, said in November that the exclusivity reduction would not allow a pharmaceutical company to recoup the investment in development as well as the cost of marketing.

More For You

UK business district
The Canary Wharf business district including global financial institutions in London.
Getty Images

Economy shrinks again in May, hitting Labour’s growth plans

THE UK economy contracted unexpectedly in May, marking the second consecutive monthly decline, according to official data released on Friday. The figures present a challenge for the Labour government as it attempts to revive economic growth.

Gross domestic product fell by 0.1 per cent in May, following a 0.3 per cent contraction in April, the Office for National Statistics (ONS) said in a statement.

Keep ReadingShow less
SBI UK cuts mortgage rates

The bank's commitment to green lending reflects focus on sustainability (Photo: Getty Images)

SBI UK cuts mortgage rates

BANKING major State Bank of India (UK) has cut interest rates on its buy-to-let mortgage products to help landlords reduce borrowing costs.

The bank said the rate cuts would help landlords invest in rental properties and meet growing demand for rental homes across the UK.

Keep ReadingShow less
LET Mining: The world's leading cloud mining platform, the best way to earn passive income

LET Mining: The world's leading cloud mining platform, the best way to earn passive income

Today, as the digital economy continues to evolve, passive income is no longer a wealth tool exclusive to the rich, but something that everyone can touch and participate in. With the integration of blockchain technology and green energy, LET Mining is providing global users with a new way of passive income: no operation, zero technical threshold, and daily income.

What is LET Mining?

LET Mining is an innovative cloud mining service platform that simplifies the complex cryptocurrency mining process into a few simple steps through cloud computing technology, allowing ordinary users to easily participate in digital currency mining and obtain stable passive income without purchasing expensive hardware equipment or mastering professional technical knowledge.

Keep ReadingShow less
JLR Tata

A logo is pictured outside a Jaguar Land Rover new car show room in Tonbridge, south east England.

JLR Q1 sales dip as US tariffs hit exports

Jaguar Land Rover (JLR) reported a 10.7 per cent drop in sales for the April–June quarter, as a temporary pause in shipments to the United States and the phase-out of Jaguar’s legacy models weighed on volumes.

The company, owned by India’s Tata Motors, sold 87,286 units to dealers worldwide during the quarter, compared to 97,755 units in the same period last year.

Keep ReadingShow less